Understand the source comparison
Peptides Joe Rogan Talked About Podcast: Research Peptides Comparison
The table below compares the three primary peptides Joe Rogan discussed on his podcast. BPC-157, TB-500, and thymosin alpha-1. Across mechanism, primary research applications, and critical sourcing considerations. BPC-157 Upregulates VEGF, promotes angiogenesi
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- The table below compares the three primary peptides Joe Rogan discussed on his podcast. BPC-157, TB-500, and thymosin alpha-1. Across mechanism, primary research applications, and critical sourcing considerations.
- BPC-157
- Upregulates VEGF, promotes angiogenesis and fibroblast migration
- Tendon/ligament repair, gastric mucosal healing
- 15 amino acids
- ≥98% (verified by HPLC)
- Most studied for localised soft tissue injury. Requires exact sequencing or receptor binding fails
- TB-500
- Binds G-actin, enhances cell migration and wound closure
- Systemic tissue repair, reduction of fibrosis
- 43 amino acids (fragment)
- ≥97% (lyophilised storage required)
- Effective for cumulative microtrauma and scar tissue modulation. Less targeted than BPC-157
- Thymosin Alpha-1
- Modulates T-cell maturation, balances Th1/Th2 cytokine response
- Immune function optimisation, viral clearance
- 28 amino acids
- ≥99% (highly sensitive to degradation)
- Primary application is immune modulation, not tissue repair. Sourcing quality determines efficacy